As numbers of studies found that cell stemness/differentiation may contribute to chemoresistance in cancers [51,52], negative correlations between PKM2 expression and stemness markers, including Sox2, CD24, and Prom1/CD133 mRNA levels, were detected in subjects from the TCGA-HNSC dataset (Figure 4B). The gene discussed is PKM; the disease is cancer.